However, in some cancers GSK3 is overexpressed20, and promotes survival by several mechanisms, including activation of the canonical21 and non-canonical22 nuclear factor-kB pathways, inhibition of apoptotic signaling and caspase activation23, and inhibition of c-Myc-induced apoptosis24. The gene discussed is MYC; the disease is cancer.